Jean-Charles Duclos-Vallée
Prof Jean-Charles Duclos-Vallée is an expert in Hepatology at Centre Hépato-Biliaire (France). As of October 2026, ScienceLeadR ranks Jean-Charles Duclos-Vallée in the top 1% of experts worldwide for Liver Transplantation, Tissue Transplantation and Hepatitis. Jean-Charles Duclos-Vallée has authored 336 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 1,228 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Hematology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1993 - 2026
Number : 336
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| In vitro space of Disse model for exploration of drug induced hepatotoxicity. PMID 41878881 — pharmaceutical preparations, liver, nanotechnology | Lab Chip | 2026 | 0 |
| [Liver organoids: from promise to functional complexity]. PMID 41860268 — cells, liver, organoids | Med Sci (Paris) | 2026 | 0 |
| Autoimmune Features in Sickle Cell Patients: A New Explanation for Liver Damage? PMID 41399995 — cells, hepatitis, autoimmune, hematology, anemia, sickle cell, liver, autoimmunity | Am J Hematol | 2025 | 0 |
| Whole Exome Sequencing in Children With Autoimmune Hepatitis Identified Mutations in Genes Involved in the mTORC1 Signaling Pathway. PMID 41234702 — cells, hepatitis, autoimmune, genes, exome, exome sequencing, mechanistic target of rapamycin complex 1, mutation, hepatitis, child | Gastro Hep Adv | 2025 | 0 |
| Features and outcomes of 280 patients with idiosyncratic drug-induced liver injury: the REFHEPS prospective study. PMID 41197933 — registries, pharmaceutical preparations, digestive system diseases, neoplasms, liver, immune checkpoint inhibitors, sex, prospective studies | Clin Gastroenterol Hepatol | 2025 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis NCT05473403 — liver diseases, hepatitis, autoimmune, liver transplantation, organ dysfunction scores, emergencies, adrenal cortex hormones, liver, hepatitis a, risk factors, liver failure, acute, therapeutics, steroids, transplantation, hepatitis, liver failure, non-responder | N/A | Not yet recruiting | 2024 |
LeadR Networks
Main global connection map